Improving Chlamydia Screening Rates

In June 2016, the American Sexual Health Association convened a meeting titled Improving Chlamydia Screening Rates: Engaging Providers, Patients and Payers that meeting brought together experts in sexual health and sexually transmitted infection (STI) prevention along with relevant stakeholders in the health insurance system to discuss strategies to improve chlamydia screening rates among young, sexually active women.

Annual routine screening of sexually active women is the best way to identify and subsequently treat women, since up to 75% of women with chlamydia have no symptoms. Screening for chlamydia is included as a HEDIS (Health Plan Employer Data and Information Set) measure since 2000. This HEDIS indicator measures the proportion of sexually active females between the ages of 15 and 24 who were screened for chlamydial infection annually.

The presentations below from the meeting offer health plans background on the issue as well as strategies employed by payers and partners to improve HEDIS scores. Click the title of each presentation to access a PDF of the slide set.

Chlamydia: An Overview

Elizabeth Torrone, MSPH, PhD, Epidemiologist
Division of STD Prevention, Centers for Disease Control and Prevention

Outreach to the Private Sector

Alyson Kristensen, MPH, Director
National Chlamydia Coalition

Chlamydia Screening Measurement

Sepheen Byron, MHS, Director of Performance Measurement
National Committee for Quality Assurance

Working with Health Departments, Community Members, Health Plans

Candy Hadsall, RN, STD Nurse Specialist, Infertility Prevention Project Coordinator
Minnesota Department of Health

Health Plans in Minnesota Partner on Chlamydia Screening

Patty Graham, Senior Quality Consultant

Ochsner Population Health

Susan Montz, BSN, MBA Director Accountable Care Organizations Performance Improvement
Ochsner Health System

Creating and Disseminating Novel Approaches

Deborah Arrindell, Vice President, Health Policy
American Sexual Health Association